Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

China flag China · Delayed Price · Currency is CNY
22.21
-0.01 (-0.05%)
Jun 18, 2025, 2:45 PM CST
11.55%
Market Cap 9.08B
Revenue (ttm) 689.61M
Net Income (ttm) -115.42M
Shares Out 407.80M
EPS (ttm) -0.28
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 9,487,073
Average Volume 13,636,602
Open 21.89
Previous Close 22.22
Day's Range 21.65 - 22.32
52-Week Range 14.86 - 25.99
Beta 0.49
RSI 61.99
Earnings Date Aug 15, 2025

About SHA:688321

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines for the treatment of human diseases in five therapeutic areas, including cancer, metabolic diseases, autoimmune disorders, central nervous system disorders, and antivirals. It is developing chidamide, a subtype-selective benzamide inhibitor of histone deacetylase (HDAC) primarily targeting subtypes 1, 2, 3 of class I HDAC; chiglitazar, a new-genera... [Read more]

Sector Healthcare
Founded 2001
Employees 1,060
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688321
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.